Image

Global Iloprost Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Global Iloprost Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Nov 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Iloprost Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 106.17 USD Million
Diagram Market Size (Forecast Year) USD 212.23 USD Million
Diagram CAGR %

Major Markets Players

  • Bayer AG
  • Vectura Group plc
  • VisionGate
  • Janssen Global Services LLC
  • TransoPharm Handels GmbH

Global Iloprost Market, By Drug Class (Polycyclic aromatic hydrocarbon (PAH), Prostacyclin Analogs, Others), Demographic (Adult, Geriatric), Application (Pulmonary Arterial Hypertension, Systemic Sclerosis, Others), Dosage Form (Solution, Other), Route of Administration (Intravenous, Inhalation), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.

Iloprost Market

Iloprost Market Analysis and Size

Iloprost is a drug that is used to treat pulmonary arterial hypertension (PAH). In patients with PAH, iloprost may help them exercise more and reduce the progression of their symptoms. Iloprost belongs to the class of drugs known as vasodilators. It acts by relaxing blood vessels throughout the body, including the lungs. It is a prostacyclin PGI2 analog that dilates the vascular beds of the systemic and pulmonary arteries. This medication is available as a solution to be inhaled through the mouth. During the day, it is commonly inhaled six to nine times. It is available under the brand name ventavis. Side effects of this drug include flushing, blurred vision, cough, headache, nausea, vomiting, tightening of jaw muscles, wheezing and breathing difficulties, among others. 

Data Bridge Market Research analyses that the Global Iloprost Market which was USD 106.17 million in 2022, would rocket up to USD  212.23 million by 2030, and is expected to undergo a CAGR of 11.50% during the forecast period 2023-2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Drug Class (Polycyclic aromatic hydrocarbon (PAH), Prostacyclin Analogs, Others), Demographic (Adult, Geriatric), Application (Pulmonary Arterial Hypertension, Systemic Sclerosis, Others), Dosage Form (Solution, Other), Route of Administration (Intravenous, Inhalation), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

Countries Covered

U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa

Market Players Covered

Bayer AG (Germany), Vectura Group plc (U.K.), VisionGate, Inc. (U.S.), Janssen Global Services, LLC (U.S.), Transo-Pharm Handels-GmbH (Germany), LGM Pharma (U.S.), Newchem (India), and YONSUNG Fine Chemicals Co., Ltd. (South Korea)

Market Opportunities

  • Advancements in Targeted Therapies and Immunotherapies
  • Growing Emphasis on Personalized Medicine and Precision Oncology

Market Definition

Iloprost, in the industry of pharmaceuticals, is a drug belonging to the anticonvulsant class of medications. It was initially developed to treat epileptic seizures, specifically partial seizures. Over time, its use has expanded to include the management of neuropathic pain and certain types of chronic pain. Iloprost functions by affecting the nerves and chemicals in the body that are involved in causing seizures and various types of pain.

Global Iloprost Market Dynamics

Drivers

  • Growing Prevalence of Neuropathic Pain Disorders

The rising incidence of neuropathic pain disorders globally is a significant driver for the iloprost market. Neuropathic pain, often associated with conditions like diabetic neuropathy, post-herpetic neuralgia, and trigeminal neuralgia, necessitates effective pain management. Iloprost has proven efficacy in managing neuropathic pain, driving its demand and adoption.

  • Expanding Applications and Off-Label Usage

Iloprost's versatility in treating various medical conditions beyond its initial intended use, such as anxiety disorders, migraines, and restless legs syndrome, contributes to market growth. Physicians and healthcare practitioners increasingly prescribe iloprost off-label for these conditions, broadening its market reach and fueling demand.

Opportunity

  • Rising Awareness and Education Initiatives

There is a substantial opportunity for market growth through increased awareness and educational initiatives regarding iloprost's benefits, optimal usage, and potential side effects. Educating healthcare professionals, patients, and caregivers about the appropriate use of iloprost, its efficacy in managing various conditions, and safety precautions can enhance its acceptance and adoption. This educational approach can not only expand the market but also foster responsible usage, which is crucial in ensuring positive outcomes and mitigating potential risks.

Restraints/Challenges

  • Concerns Regarding Abuse and Dependency

One significant restraint for the iloprost market is the rising concern regarding its potential for abuse and dependency. Reports of misuse and addiction, particularly when combined with other substances like opioids, have raised regulatory scrutiny and led to tighter control and monitoring of iloprost prescriptions. This has the potential to limit its usage and impact the overall market growth.

This iloprost market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the iloprost market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Recent Development

  • In September 2023, Pfizer Inc. and BioNTech SE announced that they received approval from the U.S. Food and Drug Administration (FDA) for their supplemental Biologics License Application (COMIRNATY 2023-2024 Formulation). This approval covers individuals aged 12 and above, and it includes emergency use authorization for children aged 6 months to 11 years, specifically for their Omicron XBB.1.5-adapted monovalent COVID-19 vaccine. The current vaccine season's recommendation is for a single dose for most individuals aged 5 and older. However, children under 5 years old may qualify for additional doses of this season's vaccine if they have not already completed a three-dose series with earlier formulations of a COVID-19 vaccine

 Global Iloprost Market Scope

The global iloprost market is segmented on the basis of product type, application, route of administration, mode of purchase, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Capsule
  • Tablet

 Application

  • Epilepsy
  • Neuropathic Pain
  • Restless Legs Syndrome

Route of Administration

  • Oral
  • Parenteral
  • Intravenous

Mode of Purchase

  • Prescription
  • Retail
  • Over the Counter

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Global Iloprost Market Regional Analysis/Insights

The iloprost market is analyzed and market size insights and trends are provided by country, product type, application, route of administration, mode of purchase, and distribution channel as referenced above.

The countries covered in the global iloprost market report are U.S., Canada, Mexico, Brazil, Argentina, Peru, rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, rest of Middle East and Africa.

North America is expected to dominate and register the highest growth rate in the iloprost market due to rise in the surge in the approvals of products for the treatment and rise in the initiatives taken by the government and pharmaceutical organizations to spread awareness regarding the disease in this region.

Asia-Pacific is the expected region in terms of growth in iloprost market due to rise in the prevalence of acute lymphocytic/lymphoblastic leukemia (ALL) in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the Market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Iloprost Market Share Analysis

The iloprost market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to iloprost market.

Some of the major players operating in the iloprost market are:

  • Bayer AG (Germany)
  • Vectura Group plc (U.K.)
  • VisionGate, Inc. (U.S.)
  • Janssen Global Services, LLC (U.S.)
  • Transo-Pharm Handels-GmbH (Germany)
  • LGM Pharma (U.S.)
  • Newchem (India)
  • YONSUNG Fine Chemicals Co., Ltd. (South Korea)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The iloprost market size will be worth USD 212.23 million by 2030.
The growth rate of the iloprost market is 11.50% in the forecast period by 2030.
The major companies in the iloprost market are Bayer AG, Vectura Group plc, VisionGate, Inc., Janssen Global Services, LLC, Transo-Pharm Handels-GmbH, LGM Pharma., Newchem, and YONSUNG Fine Chemicals Co., Ltd., among others.
Product type, application, route of administration, mode of purchase, and distribution channel are the factors on which the iloprost market research is based.
The growing prevalence of neuropathic pain disorders & expanding applications and off-label usage are the growth drivers of the iloprost market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials